Avantor Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 2/6
Avantor yıllık ortalama 37.4% oranında kazançlarını artırırken, Life Sciences sektöründe kazançlar growing at 11.7% annual. Gelirler growing yılda ortalama 3.2% oranında artmaktadır. Avantor'in özkaynak karlılığı 5.6% ve net marjı 4.5%'dir.
Anahtar bilgiler
37.4%
Kazanç büyüme oranı
42.1%
EPS büyüme oranı
Life Sciences Sektör Büyümesi | 21.5% |
Gelir büyüme oranı | 3.2% |
Özkaynak getirisi | 5.6% |
Net Marj | 4.5% |
Son Kazanç Güncellemesi | 30 Sep 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 28%?
Nov 16Avantor (NYSE:AVTR) Takes On Some Risk With Its Use Of Debt
Oct 26Avantor: Uninspiring, Even Amidst Some Green Shoots
Oct 24Why We're Not Concerned About Avantor, Inc.'s (NYSE:AVTR) Share Price
Sep 02Avantor, Inc. (NYSE:AVTR) Shares Could Be 35% Below Their Intrinsic Value Estimate
Aug 15Avantor: Yet To Evidence Economic Value For Valuation Repricing, Reiterate Hold
Aug 13At US$20.82, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?
Jul 16We Think Avantor (NYSE:AVTR) Is Taking Some Risk With Its Debt
May 22Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 32%?
Apr 26Avantor, Inc.'s (NYSE:AVTR) Popularity With Investors Is Clear
Apr 04We Think You Can Look Beyond Avantor's (NYSE:AVTR) Lackluster Earnings
Feb 21Is Avantor (NYSE:AVTR) A Risky Investment?
Feb 11Should You Think About Buying Avantor, Inc. (NYSE:AVTR) Now?
Jan 21Getting In Cheap On Avantor, Inc. (NYSE:AVTR) Might Be Difficult
Dec 31Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 23%?
Dec 09Avantor: Contracting Growth And Returns On Equity At 37x Earnings - Enemies To The Value Investor
Dec 01These 4 Measures Indicate That Avantor (NYSE:AVTR) Is Using Debt Extensively
Oct 24Is Now An Opportune Moment To Examine Avantor, Inc. (NYSE:AVTR)?
Oct 03Is There An Opportunity With Avantor, Inc.'s (NYSE:AVTR) 32% Undervaluation?
Sep 10Avantor: Customers Destocking, Order Volumes Down, Challenges To Rating (Rating Downgrade)
Sep 08Avantor (NYSE:AVTR) Has A Pretty Healthy Balance Sheet
Jul 10Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry
Jun 28At US$19.71, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?
Jun 22A Look At The Fair Value Of Avantor, Inc. (NYSE:AVTR)
Jun 04Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?
Apr 17Is Avantor (NYSE:AVTR) A Risky Investment?
Apr 04Why Avantor, Inc. (NYSE:AVTR) Could Be Worth Watching
Mar 22Avantor Non-GAAP EPS of $0.32 beats by $0.02, revenue of $1.8B beats by $10M
Feb 03Does This Valuation Of Avantor, Inc. (NYSE:AVTR) Imply Investors Are Overpaying?
Feb 02Avantor: Re-Rating To Buy, Paying Fair Price At 17x Forward P/E (Rating Upgrade)
Jan 28With EPS Growth And More, Avantor (NYSE:AVTR) Makes An Interesting Case
Jan 09Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly
Dec 27Is It Time To Consider Buying Avantor, Inc. (NYSE:AVTR)?
Dec 14Avantor: Reduce To Hold, Awaiting Convergence Of Price, Fundamentals
Nov 10Avantor Non-GAAP EPS of $0.34 beats by $0.01, revenue of $1.86B beats by $10M
Oct 28Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Oct 27Avantor raised to Buy at Citi on valuation disconnect
Oct 05Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?
Oct 03We Think Avantor (NYSE:AVTR) Can Stay On Top Of Its Debt
Sep 21Is Avantor, Inc. (NYSE:AVTR) Potentially Undervalued?
Sep 09Avantor Non-GAAP EPS of $0.37 misses by $0.01, revenue of $1.91B misses by $70M
Jul 28Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Jul 18Gelir ve Gider Dağılımı
Avantor nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Sep 24 | 6,820 | 310 | 1,616 | 0 |
30 Jun 24 | 6,826 | 360 | 1,545 | 0 |
31 Mar 24 | 6,867 | 260 | 1,497 | 0 |
31 Dec 23 | 6,967 | 321 | 1,466 | 0 |
30 Sep 23 | 7,039 | 364 | 1,470 | 0 |
30 Jun 23 | 7,176 | 423 | 1,475 | 0 |
31 Mar 23 | 7,342 | 610 | 1,469 | 0 |
31 Dec 22 | 7,512 | 662 | 1,457 | 0 |
30 Sep 22 | 7,625 | 598 | 1,442 | 0 |
30 Jun 22 | 7,603 | 572 | 1,445 | 0 |
31 Mar 22 | 7,551 | 534 | 1,463 | 0 |
31 Dec 21 | 7,386 | 508 | 1,426 | 0 |
30 Sep 21 | 7,269 | 466 | 1,442 | 0 |
30 Jun 21 | 7,040 | 267 | 1,388 | 0 |
31 Mar 21 | 6,660 | 169 | 1,345 | 0 |
31 Dec 20 | 6,394 | 52 | 1,342 | 0 |
30 Sep 20 | 6,127 | 71 | 1,336 | 0 |
30 Jun 20 | 6,026 | 135 | 1,332 | 0 |
31 Mar 20 | 6,079 | -226 | 1,334 | 0 |
31 Dec 19 | 6,040 | -335 | 1,329 | 0 |
30 Sep 19 | 5,990 | -514 | 1,294 | 0 |
30 Jun 19 | 5,981 | -554 | 1,303 | 0 |
31 Mar 19 | 5,926 | -330 | 1,305 | 0 |
31 Dec 18 | 5,864 | -356 | 1,321 | 0 |
30 Sep 18 | 5,120 | -639 | 1,215 | 0 |
31 Dec 17 | 1,247 | -415 | 376 | 0 |
31 Dec 16 | 691 | -42 | 257 | 0 |
31 Dec 15 | 637 | 22 | 185 | 0 |
Kaliteli Kazançlar: AVTR yüksek kaliteli kazançlar sağlıyor.
Büyüyen Kar Marjı: AVTR 'nin mevcut net kar marjları (4.5%) geçen yılın (5.2%) değerinden daha düşüktür.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: AVTR son 5 yılda karlı hale geldi ve kazançlarını yıllık 37.4% oranında artırdı.
Büyüme Hızlandırma: AVTR 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.
Kazançlar vs. Sektör: AVTR geçtiğimiz yıl negatif kazanç büyümesine ( -15% ) sahipti ve bu da onu Life Sciences sektör ortalamasıyla ( -4.7% ) karşılaştırmayı zorlaştırıyordu.
Özkaynak Getirisi
Yüksek ROE: AVTR 'nin Özsermaye Getirisi ( 5.6% ) düşük olarak değerlendiriliyor.